These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18372517)

  • 21. The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease.
    Dixon JM; Lumsden AB; Miller WR
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1047-50. PubMed ID: 4065177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast.
    Naldoni C; Costantini M; Dogliotti L; Bruzzi P; Bucchi L; Buzzi G; Torta M; Angeli A
    Cancer Res; 1992 Apr; 52(7):1791-5. PubMed ID: 1551110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classification.
    Borchert GH; Melegos DN; Yu H; Giai M; Roagna R; Ponzone R; Sgro L; Diamandis EP
    Clin Biochem; 1999 Feb; 32(1):39-44. PubMed ID: 10074890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncostatin M, interleukin 2, interleukin 6 and interleukin 8 in breast cyst fluid.
    Lai LC; Kadory S; Siraj AK; Lennard TW
    Int J Cancer; 1994 Nov; 59(3):369-72. PubMed ID: 7927943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The intracystic concentration of MCA in the fluid from large breast cysts].
    Mezi S; Reale MG; Aloise G; Marigliani A; Marchei CG; Sallusti E; Mentuccia D; Del Nero A; Izzo P; Modesti M
    G Chir; 1999 May; 20(5):246-51. PubMed ID: 10380368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human gross cyst breast disease and cystic fluid: bio-molecular, morphological, and clinical studies.
    Mannello F; Tonti GA; Papa S
    Breast Cancer Res Treat; 2006 May; 97(2):115-29. PubMed ID: 16331347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships of Na+ and K+ concentrations to GRP, CGRP, and calcitonin immunoreactivities and Na+,K(+)-ATPase (NKA) inhibitory activity in human breast cyst fluid.
    Weber CJ; Kim D; Costanzo M; Morris J; Howe B; Ward L; D'Agati V; McDonald T; O'Dorisio TM; Butler VP
    Ann Surg Oncol; 1994 Jul; 1(4):339-44. PubMed ID: 7850533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cyst fluid heparan sulphate is distinctively N-sulphated depending on apocrine or flattened type.
    Mannello F; Maccari F; Ligi D; Santi M; Gatto F; Linhardt RJ; Galeotti F; Volpi N
    Cell Biochem Funct; 2015 Apr; 33(3):128-33. PubMed ID: 25753066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease.
    Herruzo A; Castilla JA; Ramírez A; Marcos C; Menjón S
    Breast Cancer Res Treat; 1999 Mar; 54(2):159-64. PubMed ID: 10424406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of immunoassayable transforming growth factor-beta 1 (TGF-beta 1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal-growth-factor (EGF) content.
    Zanardi S; Pensa F; Torrisi R; De Franchis V; Barreca A; Minuto F; Boccardo F
    Int J Cancer; 1994 Dec; 59(6):725-7. PubMed ID: 7989108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids.
    Mannello F; Bocchiotti G; Bianchi G; Marcheggiani F; Gazzanelli G
    Breast Cancer Res Treat; 1996; 38(3):247-52. PubMed ID: 8739076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-Endorphin expression in gross cystic breast disease.
    Mannello F; Bocchiotti GD; Mezzolani MP; Gazzanelli G
    Cancer Lett; 1995 Mar; 89(2):189-93. PubMed ID: 7889528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cyst fluid plasmin activity and its effect on TGF-beta2 activation.
    Erbas H; Erten O; Irfanoglu ME
    Cancer Invest; 2008 Feb; 26(1):22-7. PubMed ID: 18181041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cyst type does not predict the natural history of cyst disease or breast cancer risk.
    Ebbs SR; Bates T
    Br J Surg; 1988 Jul; 75(7):702-4. PubMed ID: 3416126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical study of cyst fluid in human breast cystic disease: a review.
    Enriori CL; Novelli JE; Cremona Mdel C; Hirsig RJ; Enriori PJ
    Breast Cancer Res Treat; 1992; 24(1):1-9. PubMed ID: 1463866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apocrine cells in breast cyst fluid and their relationship to cyst type: a morphometric study.
    Beccati D; Grilli N; Schincaglia P; Naldoni C; Tavolazzi L; Ranaldi R; Dogliotti L; Torta M; Angeli A
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):597-602. PubMed ID: 3383964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentrations of soluble vascular cell adhesion molecule-1 and E-selectin in breast cyst fluid and their relation with cyst type.
    Lai LC; Siraj AK; Kadory S; Lennard TW
    Br J Surg; 1995 Jan; 82(1):83-5. PubMed ID: 7533629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between oestrogen-inducible proteins, oestradiol and electrolyte ratio in breast cyst fluid.
    Lai LC; Cornell C; Lennard TW
    Cancer Lett; 1993 Apr; 69(1):21-5. PubMed ID: 8481890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of cystic disease: the importance of cyst type.
    Dixon JM; Scott WN; Miller WR
    Br J Surg; 1985 Mar; 72(3):190-2. PubMed ID: 3978372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Some aspects of fibrocystic breast disease].
    Mizia-Stec K; Zych F
    Pol Merkur Lekarski; 1997 May; 2(11):303-6. PubMed ID: 9377675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.